Literature DB >> 9151640

Antibody reactive with Actinobacillus actinomycetemcomitans leukotoxin in early-onset periodontitis patients.

J V Califano1, B E Pace, J C Gunsolley, H A Schenkein, E T Lally, J G Tew.   

Abstract

The objective of this study was to determine whether a relationship exists between antibody reactive with the Actinobacillus actinomycetemcomitans leukotoxin and the severity of periodontal disease. Serum concentrations of antibody reactive with the leukotoxin were determined for 119 early-onset periodontitis patients and 59 non-periodontitis subjects using limiting dilution analysis on Western blots. Immunoglobulin G (IgG) antibody reactive with the A. actinomycetemcomitans leukotoxin ranged from undetectable to 29 micrograms/ml (mean = 3.13 +/- 0.97 micrograms/ml for the generalized early-onset periodontitis and 2.17 +/- 0.86 micrograms/ml for the localized juvenile periodontitis patients vs 0.32 +/- 0.24 ng/ml for 59 non-periodontitis controls), and the dominant subclass was IgG1. Analysis of the relationship between antibody reactive with A. actinomycetemcomitans sonicate, A. actinomycetemcomitans leukotoxin and attachment loss patterns indicates that seropositive generalized early-onset periodontitis patients had decreased attachment loss compared with patients lacking this antibody. The statistical relationship appeared to be stronger for the sonicate than the purified leukotoxin. These data suggest that antibody reactive with A. actinomycetemcomitans leukotoxin may be protective in early-onset periodontitis, but given that the sonicate appeared better than the leukotoxin alone, it is not likely that leukotoxin is the only antigen of importance to host defense.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9151640     DOI: 10.1111/j.1399-302x.1997.tb00362.x

Source DB:  PubMed          Journal:  Oral Microbiol Immunol        ISSN: 0902-0055


  6 in total

Review 1.  Periodontal disease as a specific, albeit chronic, infection: diagnosis and treatment.

Authors:  W J Loesche; N S Grossman
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

2.  Evaluation of the humoral immune response to the cytolethal distending toxin of Aggregatibacter actinomycetemcomitans Y4 in subjects with localized aggressive periodontitis.

Authors:  I Xynogala; A Volgina; J M DiRienzo; J Korostoff
Journal:  Oral Microbiol Immunol       Date:  2009-04

3.  Multifactorial assessment of predictors for prevention of periodontal disease progression.

Authors:  Benjamin Ehmke; Thomas Beikler; Imme Haubitz; Helge Karch; Thomas Frank Flemmig
Journal:  Clin Oral Investig       Date:  2003-08-26       Impact factor: 3.573

Review 4.  Aggregatibacter actinomycetemcomitans leukotoxin: a powerful tool with capacity to cause imbalance in the host inflammatory response.

Authors:  Anders Johansson
Journal:  Toxins (Basel)       Date:  2011-03-18       Impact factor: 4.546

5.  Nonsyndromic localized aggressive periodontitis of primary dentition: A rare case report.

Authors:  Radhika Muppa; Srinivas Nallanchakrava; Mahesh Chinta; Ravi Teja Manthena
Journal:  Contemp Clin Dent       Date:  2016 Apr-Jun

Review 6.  Pathogenicity of the highly leukotoxic JP2 clone of Aggregatibacter actinomycetemcomitans and its geographic dissemination and role in aggressive periodontitis.

Authors:  Dorte Haubek; Anders Johansson
Journal:  J Oral Microbiol       Date:  2014-08-14       Impact factor: 5.474

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.